XML 37 R25.htm IDEA: XBRL DOCUMENT v3.4.0.3
(Loss) Earnings per Share (Tables)
 3 Months Ended
Mar. 31, 2016
Earnings Per Share [Abstract]  
Computation of Basic and Diluted Loss Per Share
The following table sets forth the computation of basic and diluted (loss) earnings per share for the three months ended March 31, 2016 and 2015:
 
Three Months Ended
March 31,
 
2016
 
2015
 
(in thousands, except per share amounts)
Net (loss) income from continuing operations attributable to The Medicines Company
$
(90,343
)
 
$
4,373

(Loss) income from discontinued operations, net of tax
(2,105
)
 
661

Net (loss) income attributable to The Medicines Company
$
(92,448
)
 
$
5,034

 
 
 
 
Weighted average common shares outstanding, basic
69,210

 
65,174

Plus: net effect of dilutive stock options, warrants, restricted common shares and shares issuable upon conversion of Notes
—

 
1,755

Weighted average common shares outstanding, diluted
69,210

 
66,929

 
 
 
 
Basic (loss) earnings per common share attributable to The Medicines Company:
 
 
 
(Loss) earnings from continuing operations
$
(1.31
)
 
$
0.07

(Loss) earnings from discontinued operations
(0.03
)
 
0.01

Basic (loss) earnings per share
$
(1.34
)
 
$
0.08

 
 
 
 
Diluted (loss) earnings per common share attributable to The Medicines Company:
 
 
 
(Loss) earnings from continuing operations
$
(1.31
)
 
$
0.07

(Loss) earnings from discontinued operations
(0.03
)
 
0.01

Diluted (loss) earnings per share
$
(1.34
)
 
$
0.08